Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 10, 2025 • 6:30 AM ET

Date/Time Source News Release
06/05/2025 08:00 AM EDT Business Wire Lineage Cell Therapeutics Announces Updates to the 3rd Annual Spinal Cord Injury Investor Symposium
05/14/2025 08:00 AM EDT Business Wire Lineage to Present at 3rd Annual H.C. Wainwright BioConnect Investor Conference at Nasdaq NYC
05/13/2025 04:01 PM EDT Business Wire Lineage Cell Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
05/12/2025 08:00 AM EDT Business Wire RG6501 (OpRegen®) Phase 1/2a Clinical Study 36 Month Results to Be Featured at Clinical Trials at the Summit 2025
05/01/2025 08:00 AM EDT Business Wire Lineage Cell Therapeutics to Report First Quarter 2025 Financial Results and Provide Business Update on May 13, 2025
04/22/2025 08:00 AM EDT Business Wire Lineage Cell Therapeutics and the Christopher & Dana Reeve Foundation Proudly Announce the 3rd Annual Spinal Cord Injury Investor Symposium
04/21/2025 08:00 AM EDT Business Wire Lineage to Present at 2025 Eyecelerator Meeting Sponsored by the American Academy of Ophthalmology (AAO)
03/10/2025 04:05 PM EDT Business Wire Lineage Cell Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
03/05/2025 08:00 AM EST Business Wire Lineage Cell Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Business Update on March 10, 2025
02/11/2025 08:00 AM EST Business Wire Lineage Initiates Clinical Study of OPC1 for Spinal Cord Injury
Page

Additional News

As of June 10, 2025 • 6:30 AM ET

Date/Time Source News Release
05/13/2025 05:53 PM EDT SeekingAlpha Lineage Cell Therapeutics outlines manufacturing milestone and anticipates OpRegen 36-month data update while advancing OPC1 clinical plans
05/13/2025 05:53 PM EDT SeekingAlpha Lineage Cell Therapeutics, Inc. (LCTX) Q1 2025 Earnings Call Transcript
05/13/2025 05:10 PM EDT Zacks Lineage Cell (LCTX) Reports Q1 Loss, Lags Revenue Estimates
05/13/2025 04:10 PM EDT SeekingAlpha Lineage Cell Therapeutics GAAP EPS of -$0.02 beats by $0.01, revenue of $1.50M misses by $0.22M
05/13/2025 10:00 AM EDT SeekingAlpha Here are the major earnings after the close today
05/12/2025 05:45 PM EDT Zacks Editas Medicine (EDIT) Reports Q1 Loss, Tops Revenue Estimates
03/10/2025 08:16 PM EDT SeekingAlpha Lineage Cell Therapeutics, Inc. (LCTX) Q4 2024 Earnings Call Transcript
03/10/2025 05:25 PM EDT Zacks Lineage Cell (LCTX) Reports Q4 Loss, Tops Revenue Estimates
03/10/2025 04:08 PM EDT SeekingAlpha Lineage Cell Therapeutics GAAP EPS of $0.02 beats by $0.05, revenue of $2.9M beats by $1.28M
03/10/2025 10:00 AM EDT SeekingAlpha Here are the major earnings after the close today
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.